Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?
Conte G, Costabile G, Baldassi D, Rondelli V, Bassi R, Colombo D, Linardos G, Fiscarelli EV, Sorrentino R, Miro A, Quaglia F, Brocca P, d'Angelo I, Merkel OM, Ungaro F.
Conte G, et al.
ACS Appl Mater Interfaces. 2022 Feb 16;14(6):7565-7578. doi: 10.1021/acsami.1c14975. Epub 2022 Feb 2.
ACS Appl Mater Interfaces. 2022.
PMID: 35107987
Free PMC article.